Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 1
2012 2
2013 1
2014 6
2015 3
2016 1
2017 2
2018 3
2019 1
2020 3
2021 4
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Astatine-211: production and availability.
Zalutsky MR, Pruszynski M. Zalutsky MR, et al. Among authors: pruszynski m. Curr Radiopharm. 2011 Jul;4(3):177-85. doi: 10.2174/1874471011104030177. Curr Radiopharm. 2011. PMID: 22201707 Free PMC article. Review.
Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy.
Radchenko V, Morgenstern A, Jalilian AR, Ramogida CF, Cutler C, Duchemin C, Hoehr C, Haddad F, Bruchertseifer F, Gausemel H, Yang H, Osso JA, Washiyama K, Czerwinski K, Leufgen K, Pruszyński M, Valzdorf O, Causey P, Schaffer P, Perron R, Maxim S, Wilbur DS, Stora T, Li Y. Radchenko V, et al. Among authors: pruszynski m. J Nucl Med. 2021 Nov;62(11):1495-1503. doi: 10.2967/jnumed.120.261016. Epub 2021 Jul 22. J Nucl Med. 2021. PMID: 34301779 Free PMC article.
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy.
Puttemans J, Stijlemans B, Keyaerts M, Vander Meeren S, Renmans W, Fostier K, Debie P, Hanssens H, Rodak M, Pruszynski M, De Veirman K, Vanderkerken K, Lahoutte T, Morgenstern A, Bruchertseifer F, Devoogdt N, D'Huyvetter M. Puttemans J, et al. Among authors: pruszynski m. Mol Cancer Ther. 2022 Jan;21(1):159-169. doi: 10.1158/1535-7163.MCT-21-0220. Epub 2021 Oct 19. Mol Cancer Ther. 2022. PMID: 34667109 Free PMC article.
Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody.
Pruszynski M, Koumarianou E, Vaidyanathan G, Revets H, Devoogdt N, Lahoutte T, Zalutsky MR. Pruszynski M, et al. Nucl Med Biol. 2013 Jan;40(1):52-9. doi: 10.1016/j.nucmedbio.2012.08.008. Epub 2012 Nov 15. Nucl Med Biol. 2013. PMID: 23159171 Free PMC article.
N-Succinimidyl 3-((4-(4-[(18)F]fluorobutyl)-1H-1,2,3-triazol-1-yl)methyl)-5-(guanidinomethyl)benzoate ([(18)F]SFBTMGMB): a residualizing label for (18)F-labeling of internalizing biomolecules.
Vaidyanathan G, McDougald D, Choi J, Pruszynski M, Koumarianou E, Zhou Z, Zalutsky MR. Vaidyanathan G, et al. Among authors: pruszynski m. Org Biomol Chem. 2016 Jan 28;14(4):1261-71. doi: 10.1039/c5ob02258d. Epub 2015 Dec 8. Org Biomol Chem. 2016. PMID: 26645790 Free PMC article.
27 results